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This study aimed to evaluate the eﬀect of transcutaneous electric acupoint stimulations (TEAS) on body composition and heart
ratevariability(HRV)inpostmenopausalwomenwithobesity.Inthisprospective study,49postmenopausalwomenwererecruited
in Taiwan. Body composition was used as a screening test for obesity (percentage body fat > 30%, waist circumference > 80 cm).
Theexperimentalgroup(n=24)received TEAStreatment 30mintwiceperweekfor12weeksattheZusanli(ST36)andSanyinjiao
(SP 6) acupoints. The control group (n = 25) did not receive any intervention. The study of HRV was analyzed by time (standard
deviation of the normal-to-normal (NN) intervals (SDNN) and square root of the mean squared diﬀerences of successive NN
intervals (RMSSD)indices) andfrequency domainmethods. Powerspectral componentswere obtained at low (LF) andhigh (HF)
frequencies. Body composition and HRV values were measured at the 4th, 8th, and 12th weeks. A total of 40 subjects completed
this study. Waistcircumference and percentage body fatin the experimental group (n = 20) were signiﬁcantlyless than thoseofthe
control group (n = 20) at the 8th and 12th weeks (all P < .05). Additionally, at the same time points, percentage lean body mass in
the experimental group was signiﬁcantly greater than that in the control group (P < .05). SDNN values increased signiﬁcantly at
the4th and8th weeks when comparedwith thecontrol group(allP <.05).At 12weeks,SDNN valuewasnotsigniﬁcantlydiﬀerent
from that of the control group (P = .105). TEAS treatment improves body composition, and has a transient eﬀect on the HRV in
postmenopausal women with obesity.
1.Introduction
In 2005, ∼1.6 billion adults worldwide were overweight, and
at least 400 million adults were obese. World Health Organi-
zation projections indicate that by 2015, ∼2.3 billion adults
will be overweight and more than 700 million will be obese
[1]. In Taiwan, the prevalence of obesity (BMI ≥ 25) in men
is 24.8% and in women 25.5% [2].
The prevalence of being overweight generally arises
between the ages of 20 and 60 years, and overall it seems
that while men gain more body weight earlier in life, women
tend to accumulate more body weight during the transition
through menopause [3–5]. The increase in adiposity during
menopause seems to be a consequence of the decline in
endogenous estrogens and reduced energy expenditure [4,
6]. Redistribution of body fat with increased visceral fat is
believed to correlate with increased prevalence of metabolic
syndrome, and consequently, cardiovascular disease in post-
menopausal women [7, 8].
The autonomic nervous system plays an important role
in the regulation of energy expenditure and body fat
storage [9, 10]. Studies have shown that regional body fat
distribution varied with the heart rate variability (HRV) of
obese subjects and weight loss increased parasympathetic
control of HRV [11, 12]. Reduced sympatho-vagal activity
has also been observed in women after menopause [13], and
isassociatedwithhigherbodyfatcontent,bloodpressureand
blood lipid concentrations in postmenopausal women [14].2 Evidence-Based Complementary and Alternative Medicine
Non-random allocation
49 female volunteers were recruited
for the study
24 allocated to TEAS
treatment 2 sessions per
week for 12 weeks
25 allocated to control group
with no intervention
Dropped out,
n = 2 due to missed
treatment sessions
n =2 due to missed
measurements
Analyzed (n = 20)
Dropped out,
n = 3 due to missed
measurements
n =2d u et o
hospital admission
Analyzed (n = 20)
Body composition and HRV
measured at the initial
evaluation and repeated at
the 4th, 8th, and 12th week.
Figure 1: Flow chart of the distribution of the cohort study.
Accordingly, modulation of sympathetic and/or parasym-
pathetic activity may play a role in regulating body fat
composition, lipid metabolism, and cardiovascular proﬁles
after menopause.
Acupuncture has been applied extensively around the
world as an alternative treatment to reduce body weight
[15]. The underlying mechanisms of acupuncture in weight
reduction might result from reducing appetite [16]a n d
mobilizing the body energy depots through lipolytic eﬀect
[17]. Several studies have suggested that acupuncture and
acupuncture point procedures could also modulate the
activities of the sympathetic and parasympathetic nerves
[18, 19], with an eﬀect of increased vagal modulation [20,
21]. Site-speciﬁc eﬀects of acupuncture on gastric motility
have been demonstrated in rats, and HRV analysis is useful
to evaluate the eﬃcacy of acupuncture on the activity of
autonomic nervous system [22].
The purpose of this study was to evaluate the eﬀect of
transcutaneous electrical acupoint stimulation (TEAS) on
body compositionand HRVinpostmenopausal womenwith
obesity. The Zusanli (ST 36) and Sanyinjiao (SP 6) were
selected as main acupoints in the treatment group.
2.Methods
2.1. Subjects. This was a prospective study conducted from
November 2006 to June 2007. All study procedures were
approved by the committee review board at the National
Taipei College of Nursing. A total of 49 female volunteers
were recruited from communities in Taipei. Written consent
was obtained before their participation in the study. Initial
evaluation included measurements of body composition
(i.e., body weight, waist circumference, hip circumference,
waist-hip ratio, percentage body fat and percentage lean
body mass). Weight was measured to the nearest 0.1kg using
an electronic scale. Waist circumference was measured at
the level midway between the lateral lower rib margin and
iliac crest. Hip circumference was measured at the levels
of the trochanters in the standing position. A bioelectrical
impedance analyzer system (BT-905 Body Composition
Analyzer, Skylark Co. Ltd., Taiwan) was used to measure
body fat and lean mass. All participants met the following
criteria: (i) had experienced menopause naturally at least
1 year previously, (ii) <64 years of age, (iii) >30% body
fat, and (iv) waist circumference > 80cm. Individuals with
the following conditions were excluded: (i) gynecological
disease including hysterectomy and/or oophorectomy, (ii)
history of cancer, (iii) cardiac arrhythmia or an implanted
cardiac pacemaker, (iv) paralysis of lower limbs or decreased
sensation, and (v) inﬂammation of skin defects exhibited in
skin of lower limbs.
2.2. Groups and Intervention. The 49 women were random-
ized into the treatment (n = 24) and control groups (n = 25).
A TEAS device using interferential current (Skylark 730IF,
Skylark Device & Systems Co. Ltd, Taiwan) was applied.Evidence-Based Complementary and Alternative Medicine 3
Table 1: Characteristics of study subjects.
Variables Control
(n = 20)
Experimental
(n = 20) P-value
Age (years)a 52.5 (48.0,
61.0) 57.0 (49.0, 63.0) .004∗
Duration of
menopause (years)a 2.5 (1.0, 10.0) 5.0 (1.0, 10.0) .148
Marriageb 1.000
Married 20 (100.00) 19 (95.00)
Widow 0 1 (5.00)
Occupationb .004∗
No 19 (95.00) 11 (55.00)
Yes 1 (5.00) 9 (45.00)
Exerciseb .457
Never 4 (20.00) 1 (5.00)
Occasional 7 (35.00) 8 (40.00)
Regular 9 (45.00) 11 (55.00)
Teab .693
No 3 (15.00) 4 (20.00)
Occasional 5 (25.00) 7 (35.00)
Frequently 12 (60.00) 9 (45.00)
Coﬀeeb .236
No 9 (45.00) 7 (35.00)
Occasional 3 (15.00) 8 (40.00)
Frequently 8 (40.00) 5 (25.00)
Medical historyb .487
No 9 (45.00) 5 (25.00)
Yes 11 (55.00) 15 (75.00)
Medicationsb 1.000
No 14 (70.00) 14 (70.00)
Yes 6 (30.00) 6 (30.00)
Health foodb .465
No 6 (30.00) 4 (20.00)
Yes 14 (70.00) 16 (80.00)
Stressb .046∗
Light 14 (70.00) 6 (30.00)
Medium 5 (25.00) 9 (45.00)
Heavy 1 (5.00) 5 (25.00)
Data are presented as median (range) or number (%).
aMann-Whitney U-test was used; bChi-square test was used.
∗Signiﬁcantly diﬀerent, P < .05.
Its speciﬁcations are as follows: maximum output current
50mA, output voltage 0–25V and wave width 125μA;
two diﬀerent frequency modulations (FM) are mixed, the
frequency of channel one set at 4000Hz and channel two at
61Hz. The treatment was 30min per session, two sessions
perweekfor12weeksusingtwosurface electrodes,onetothe
Zusanli (ST36) and the other to Sanyinjiao (SP6) acupoint.
We used close-by point to complete an electric circuit rather
than use the point in the opposite extremity, thereby letting
the current pass through the cardiac region. The control
group did not receive any intervention. Measurements of
Table 2: Body composition of the two study groups by mixed
model.
Variables Control
(n = 20)
Experimental
(n = 20) P-value
Body weight (kg)
Baseline 64.52 ± 5.97 63.48 ± 4.90 .752
4th week 65.05 ± 6.11 62.93 ± 4.78 .495
8th week 65.46 ± 6.10 62.67 ± 4.66 .219
12th week 65.68 ± 6.01 62.40 ± 4.81 .192
Waist circumference
(cm)
Baseline 84.25 ± 3.55 84.25 ± 2.69 .977
4th week 84.93 ± 4.21 83.50 ± 2.61 .525
8th week 85.60 ± 3.76 82.80 ± 2.56 .028∗
12th week 85.78 ± 3.56 82.33 ± 2.75 .006∗
Hip circumference
(cm)
Baseline 101.15 ± 3.90 101.00 ± 3.40 .732
4th week 101.55 ± 4.16 100.45 ± 3.03 .962
8th week 102.33 ± 3.96 100.03 ± 3.16 .264
12th week 102.50 ± 4.05 99.80 ± 3.28 .145
Waist to hip ratio (%)
Baseline 0.83 ± 0.02 0.84 ± 0.03 .676
4th week 0.84 ± 0.03 0.83 ± 0.02 .476
8th week 0.84 ± 0.03 0.83 ± 0.02 .096
12th week 0.84 ± 0.03 0.83 ± 0.02 .052
Body fat (%)
Baseline 35.51 ± 4.26 35.78 ± 4.23 .600
4th week 37.52 ± 5.04 34.88 ± 3.64 .166
8th week 38.69 ± 3.62 34.29 ± 3.52 .002∗
12th week 38.73 ± 3.60 33.33 ± 4.35 <.001∗
Lean body mass (%)
Baseline 64.49 ± 4.26 64.23 ± 4.23 .601
4th week 62.52 ± 5.06 65.13 ± 3.64 .172
8th week 61.31 ± 3.62 65.72 ± 3.52 .002∗
12th week 61.27 ± 3.63 66.66 ± 4.34 <.001∗
Data are presented as mean ± SD. Work, occupation, and stress were
adjusted. Bonferroni correction with adjusted α-level (α  = 0.05/3 = 0.0167)
was used for multiple comparisons between each time point and the
baseline. No diﬀerence between a time point and the baseline was found.
∗Signiﬁcantlydiﬀerent between two groups, P < .05.
body composition and HRV that were performed at the
initial evaluation were repeated at the 4th, 8th, and 12th
week.
2.3. HRV Analysis. HRV was recorded in the sitting position
after a 5-min rest and in a quiet room at room tempera-
ture using the Heart Rate Variability Analyzer (SA-3000P,
Medicore Co. Ltd, Seoul, Korea). The sensor of HRV was
clipped on the index ﬁnger (2nd ﬁnger) of the left hand.
The subjects were asked to keep silence and stay inactive
during the measurement. The subjects were earlier told to
avoid strenuous physical activity, and alcohol and coﬀee4 Evidence-Based Complementary and Alternative Medicine
Table 3: Heart rate variability of the two study groups by mixed
model.
Variables Control
(n = 20)
Experimental
(n = 20) P-value
HR (bpm)
Baseline 76.15 ± 11.71 75.95 ± 9.46 .093
4th week 75.20 ± 11.46† 71.70 ± 10.00† .399
8th week 78.65 ± 12.17† 71.30 ± 7.54† .060
12th week 75.75 ± 7.95† 71.20 ± 7.14† .331
SDNN (ms)
Baseline 27.74 ± 12.63 28.95 ± 11.04 .609
4th week 25.29 ± 12.32 42.51 ± 21.62† .024∗
8th week 25.40 ± 13.25 37.47 ± 12.90 .029∗
12th week 24.93 ± 12.75 37.84 ± 13.11 .105
RMSSD (ms)
Baseline 28.44 ± 16.40 22.94 ± 17.02 .079
4th week 32.83 ± 24.97 19.48 ± 11.81 .082
8th week 27.68 ± 15.69 20.40 ± 16.21 .125
12th week 26.16 ± 11.84 20.61 ± 13.33 .629
Total power (ms2)
Baseline 591.67 ± 479.69 830.37 ±
773.41 .225
4th week 589.58 ± 766.77 1837.12 ±
2060.79 .049∗
8th week 608.76 ± 761.64 1160.05 ±
866.09 .066
12th week 553.31 ± 610.40 1272.76 ±
1126.29 .158
LF (ms2)
Baseline 177.61 ± 205.10 244.26 ±
270.26 .409
4th week 186.34 ± 434.22 498.67 ±
522.62 .130
8th week 157.74 ± 244.64 346.60 ±
336.71 .114
12th week 162.73 ± 233.30 433.18 ±
533.66 .360
HF (ms2)
Baseline 161.50 ± 229.62 185.87 ±
265.58 .643
4th week 113.33 ± 159.14 266.32 ±
383.74 .152
8th week 150.99 ± 232.14 183.19 ±
161.47 .420
12th week 127.57 ± 157.84 161.13 ±
120.27 .980
LF nu
Baseline 52.76 ± 25.30 57.22 ± 20.96 .285
4th week 64.04 ± 16.35 54.35 ± 16.58 .441
8th week 61.84 ± 18.12 55.28 ± 16.56 .902
12th week 61.94 ± 18.93 54.94 ± 16.24 .725
HF nu
Baseline 47.24 ± 25.30 42.78 ± 20.96 .285
4th week 35.96 ± 16.35 45.65 ± 16.58 .441
8th week 38.16 ± 18.12 44.72 ± 19.75 .902
12th week 38.06 ± 19.83 45.06 ± 16.24 .725
LF/HF ratio
Table 3: Continued.
Variables Control
(n = 20)
Experimental
(n = 20) P-value
Baseline 2.24 ± 2.36 2.47 ± 3.31 .541
4th week 1.56 ± 1.18 3.06 ± 3.70 .299
8th week 1.99 ± 2.37 2.62 ± 2.94 .644
12th week 1.50 ± 0.87 2.60 ± 2.37 .345
HR, heart rate; SDNN, standard deviation of normal-to-normal RR inter-
vals; RMSSD, the square root of the mean squared diﬀerences of successive
NN intervals; LF, low frequency; HF, high frequency; LF nu, LF in
normalized unit ; HF nu, HF in normalized unit ; Data were presented as
mean ± SD. Work, occupationandworking stresswere adjusted. Bonferroni
correctionwithadjustedα-level(α  = 0.05/3 =0.0167)wasusedformultiple
comparisons between each time point and the baseline.
∗Signiﬁcantlydiﬀerent between two groups, P < .05; †Signiﬁcantlydiﬀerent
between the present time point and the baseline, P < .0167.
intake within 24h before the measurement. HRV analysis
was performed according to the guidelines of the Task
Force of the European Society of Cardiology [23]. The
following time domain parameters were evaluated: SDNN
(ms), that is, the standard deviation of the normal-to-
normal (NN) intervals; RMSSD (ms), that is, the square
root of the mean squared diﬀerences of successive NN
intervals. SDNN reﬂected overall HRV, whereas RMSSD was
considered to be an index of parasympathetic modulations
of heart rate. The frequency domains of HRV components
were obtained at low (LF 0.04–0.15Hz) and high (HF
0.15–0.4Hz) frequencies, in absolute units (ms2), and the
normalized units were computed by dividing the absolute
p o w e ro fag i v e nL Fo rH Fc o m p o n e n t( m s 2)b yt h et o t a l
power minus very low frequency (0.003–0.04Hz) power and
then multiplying this ratio by 100. The LF domain reﬂects
both the sympathetic and the parasympathetic nervous
systems and the HF domain primarily reﬂects vagal cardiac
control; the LF/HF ratio was calculated to determine the
sympatho-vagal balance [23].
2.4. Data Analysis. Power analysis by SSIZE software was
used to calculate the sample size, with signiﬁcance level at
0.05; the power of the test of 0.8 showed that 22 women were
needed in each group. Continuous variables were expressed
as median and range. Age and duration of menopause were
also expressed as median and range because they did not
follow a normal distribution. For the categorical variables,
the frequency and the percentage were shown. The Mann-
Whitney U-test for continuous variables and the chi-square
test for categorical variables were used to test for diﬀerences
between the two groups at baseline. A mixed model was
established to examine the eﬀect on a group at each time
point and the time trend for a given group. Bonﬀeroni
correction with an adjusted α level of 0.0167 (α  = 0.05/3 =
0.0167) was used to test the diﬀerence between a time point
and the baseline. All analyses were performed by SAS version
9.1.3software (SASInc,Cary,NC).P <.05wasdeﬁnedasthe
signiﬁcance level.Evidence-Based Complementary and Alternative Medicine 5
3.Results
3.1. Demographic and Anthropometric Parameters. A total of
40 subjects completed this study (Figure 1). Four subjects
in the experimental group and ﬁve subjects in the control
group dropped out due to missed treatment sessions (n =
2), missed measurements (n = 5), and hospital admission
(n = 2). Baseline characteristics are summarized in Table 1.
At baseline, the epidemiological characteristics of both
groups were similar (P > .05), but the median age of the
experimental group was greater than that of the control
group (P = .004). The median age and the median duration
of menopause of the control group were 52.5 and 2.5yrs,
respectively. The median age and the median duration of
menopause of the experimental group were 57 and 5yrs,
respectively.
The results of mixed model analysis with covariates for
body composition are shown in Table 2.T h eb o d yc o m p o s i -
tions of the two groups were similar at baseline (P > .05).
After adjustment for age, occupation, and working stress,
the mixed model analysis indicated signiﬁcant diﬀerences
in waist circumference, percentage body fat, and percentage
leanbodymassbetweenthecontrolandexperimentalgroups
at the 8th and the 12th week (P < .05). At the 8th week,
t h ew a i s tc i r c u m f e r e n c ea n dt h ep e r c e n t a g eb o d yf a to ft h e
experimental group were less than those of the control group
(P = .028 and .002, resp.). At the 12th week, when compared
with the control group, the waist circumference and the
percentage body fat of the experimental group were less (P
= .006 and <.001, resp.) and the percentage lean body mass
was greater (P < .001).
3.2. HRV. Table 3 presents the analytical results for HRV
parameters by the mixed model. When compared with the
control group, the SDNN and the total power were higher
at the 4th week (P = .024 and .049, resp.). The SDNN was
also greater for the experimental group (P = .029) at the
8th week. However, the SDNN for the experimental group
was not elevated signiﬁcantly at the 12th week (P = .105).
T h ec h a n g e si nt h eL F( n u ) ,H F( n u )a n dL F / H Fr a t i of r o m
baseline to 12th week were not statistically diﬀerent between
the two groups.
3.3. Discussion. Our study showed that at the 8th and 12th
weeks of TEAS treatment, waist circumference and percent-
age body fat in the experimental group were signiﬁcantly
less than those of the control group. The treatment did
not result in weight loss or a smaller hip circumference
than the non-treatment group. This might be explained by
the fact that women in the treatment group demonstrated
an increase in lean mass. Our data are consistent in that
waist circumference was the most aﬀected variable in the
previous trials of electro-acupuncture treatment in obese
women [24, 25]. Previous studies of acupuncture for the
treatment of obesity have focused on weight reduction and
mosttrialsshowedonlymodesteﬀectontheweightloss[15].
The directeﬀectofacupunctureonbodyfat compositionhas
not been explored before. We found that TEAS was able to
reduce fat mass, increase lean body mass and reduce waist
circumference.
We also demonstrated that a decrease of body fat
mass and waist circumference was accompanied with a
withdrawal of the sympathetic activity indicated by the
increase of SDNN: this parameter is negatively inﬂuenced by
thesympatheticcompoundoftheautonomicnervoussystem
[23]. The increase in the component of HRV at 4 and 8
weeks was probably not due to the eﬀect of weight loss on
the sympathetic activity because there were no signiﬁcant
diﬀerencesinbodyweightbetweenthetreatmentandcontrol
groups. As a result, these changes may indicate a shift
of sympathetic-vagal balance toward reduced sympathetic
tone and vagal predominance after TEAS treatment. At the
12th week of treatment, we observed a partial sympathetic
reactivation, as indicated by no signiﬁcant changes of SDNN
as compared with the control groups.
It is well established that the coordination of energy
homeostasis relies on the normal functioning of the sympa-
thoadrenal system [9,10].Ours tud yc on ﬁ rm sth er es ultsofa
previous study that showed reduced sympathovagal activity
to be associated with higher postmenopausal body fat
content [13]. The dysregulation of energy metabolism could
induce an increase in total adiposity and a redistribution of
f a tt ot h ea b d o m i n a lr e g i o n[ 3–5]. In obese women, reduc-
tion of body weight can increase parasympathetic control of
HRV signiﬁcantly [13], but the increase is temporary if body
weight does not remain controlled [26]. We found that waist
circumference and percentage body fat of the experimental
group remained less than those of the control group at
the 12th week, despite the restoration of cardiac autonomic
function. This may suggest a local eﬀect of TEAS on the
abdominal fat in favor of adipose tissue lipolysis.
The treatment principles of Traditional Chinese
Medicine for obesity are reinforcing Qi, resolving dampness,
invigorating the spleen, and nourishing the kidney [27].
The primary acupoints used in this study were Zusanli
(ST36) and Sanyinjiao (SP6). The Zusanli was used for
improving the stomach and invigorating the spleen to
remove dampness and phlegm. The Sanyinjiao was used for
eliminating water and dampness. Stimulation of acupoints
improves Qi and blood circulation [28] and subsequently
activates the metabolism to increase energy consumption
[29].
Both auricular and somatic acupoints have been shown
to be eﬀective in the acupuncture treatment of obesity
[15]. The modes of stimulation include manual needling,
mechanical pressure (acupressure), heating (moxibustion)
and transcutaneous electrical nerve stimulation (TENS).
Electrical stimulation applied on needles inserted into the
acupoints has the advantage of using precisely identiﬁed
frequency and intensity during the acupuncture treatment
[30]. Evidence from the rat experiment indicated that
electroacupuncture at body points produced a signiﬁcant
reduction of both food intake and the body weight, with
2Hzmoreeﬀective than 100Hz. Electroacupuncture could
also produce a reduction of plasma level of total cholesterol
and triglyceride, with 100Hz more eﬀective than 2Hz. It is
supposed that the 2/100Hz alternative mode of stimulation6 Evidence-Based Complementary and Alternative Medicine
may have dural eﬀect on both appetite and fat metabolism,
butthisstilllacksconvincingclinicalevidence[31].Medium-
frequency alternating currents deﬁned as currents in the
frequency range from 1 to 10kHz, are used mainly in reha-
bilitation [32]. Transcutaneous stimulation using medium-
frequency alternating currents provides a higher proportion
of electrical energy to stimulate the underlying tissue than
the conventional TENS device [33]. However, further studies
in comparing their eﬀectiveness are warranted. Using a
portable device of TENS as used in this study may provide
an alternativeforindividuals who want tomanage theweight
loss for a longer period of time.
The limitations of this study include the small sample
size, relatively short study period, and the lack of adequate
control for possible placebo eﬀects. Also, a subject’s mental
status, setting, room temperature, body position, mood
and movement all inﬂuence heart rate. Setting and room
temperature were controlled, but it was diﬃcult to account
for a patient’s mood or mental status. Since the study was
cross-sectional, we cannot make causal inferences about
relationships between obesity and postmenopausal status.
And lastly, treating ﬁxed acupoints as this study might not
fully demonstrate the eﬀect of TEAS. More acupuncture
points should be considered in further investigations.
4.Conclusions
Transcutaneous electrical stimulation of the Zusanli (ST
36) and Sanyinjiao (SP 6) acupoints was eﬀective in
reducing percentage body fat and waist circumference in
postmenopausal women during a period of 12 weeks. This
eﬀect may be related to modulation of the autonomic
nervous system and reﬂected in increased HRV components.
Further study is warranted, especially, in the evaluation of
long-term eﬀect.
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